FDA To Assess Antibiotic Linked To Woes

December 15, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

WASHINGTON - Federal health officials said Thursday they would ask outside experts whether the benefits of an antibiotic linked to rare reports of severe liver problems, including several deaths, outweigh its risks. >>> Discuss This Story

Twitter
LinkedIn
Facebook
Email
Print

Food and Drug Administration (FDA)